Atlas Trials

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Clinical trial NCT02831959 · COMPLETED

Trial details

NCT number
NCT02831959
Sponsor
NovoCure GmbH
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
Start date
2016-07-01
Primary completion
2024-11-29
Enrollment
298

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.